-The Times of India The inflation rate slowed to a more than three-year low of 5.96% in March on the back of softening vegetable, fruits and milk prices, brightening the prospect of an interest rate cut by RBI while bringing relief for the politically beleaguered government. Lower interest rates would provide relief to thousands of borrowers reeling under the burden of high equated monthly installments ( EMIs) on their home loans. Data released...
More »SEARCH RESULT
Total Matching Records found : 2650
Hunger stalks villagers in drought-hit Maharashtra-Nita Bhalla
-Reuters Millions of people in Maharashtra are at serious risk of hunger after two years of low rainfall, coupled with poor management of water resources, have left dams empty, farmland parched and cattle emaciated, aid agencies warned on Thursday. Maharashtra -- one of the country's biggest producers of sugar, pulses, cotton and soybeans -- is reeling from the worst drought in more than four decades after receiving less than 50 percent of...
More »3 IITs among top 100 universities in Asia -M Ramya
-The Times of India CHENNAI: Only three institutes in the country, all of them Indian Institutes of Technology, feature among the top 100 universities in Asia, according to the first Asia University Rankings released by "Times Higher Education" magazine. While IIT-Kharagpur is ranked 30th, IIT-Bombay is 33rd and IIT-Roorkee 56th, the University of Tokyo secured the pole position with an overall score of 78.3, followed by the National University of Singapore...
More »Finally, the patients prevail -Sarah Hiddleston
-The Hindu The Supreme Court has denied Novartis a patent for its anti-cancer drug Gleevec. This leaves the door open for Indian pharmaceutical companies to produce their own versions of the drug. Since these are sold at roughly one tenth of the patented brand price, for thousands of cancer patients it means the difference between medicine and no medicine at all. It is not just cancer patients that will benefit, but...
More »Patent justice-Sakthivel Selvaraj
-The Hindu Drug patents are designed to create profits that enable more research on diseases affecting millions. But in practice, they have often generated super profits for big pharma companies while erecting access barriers for the poor. The Novartis case spotlights much that is wrong with the system. The rejection of the Novartis petition challenging one of the most progressive tenets of the Indian Patents Act (1970), as amended in 2005 by...
More »
